IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 12 05 2023
revised: 25 09 2023
accepted: 04 10 2023
medline: 27 11 2023
pubmed: 15 10 2023
entrez: 14 10 2023
Statut: ppublish

Résumé

The important bacterial pathogen Streptococcus pyogenes secretes IdeS (immunoglobulin G-degrading enzyme of S. pyogenes), a proteinase that cleaves human immunoglobulin G (IgG) antibodies in the hinge region resulting in Fc (fragment crystallizable) and F(ab')

Identifiants

pubmed: 37838172
pii: S0021-9258(23)02373-6
doi: 10.1016/j.jbc.2023.105345
pmc: PMC10654033
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Cysteine Endopeptidases EC 3.4.22.-
Immunoglobulin Fc Fragments 0
Immunoglobulin G 0
Peptide Hydrolases EC 3.4.-
Mac-1-like protein, Streptococcus 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105345

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Inga-Maria Frick (IM)

Division of Infection Medicine, Department of Clinical Science, Lund University, Lund, Sweden. Electronic address: inga-maria.frick@med.lu.se.

Lotta Happonen (L)

Division of Infection Medicine, Department of Clinical Science, Lund University, Lund, Sweden.

Sebastian Wrighton (S)

Division of Infection Medicine, Department of Clinical Science, Lund University, Lund, Sweden.

Pontus Nordenfelt (P)

Division of Infection Medicine, Department of Clinical Science, Lund University, Lund, Sweden.

Lars Björck (L)

Division of Infection Medicine, Department of Clinical Science, Lund University, Lund, Sweden. Electronic address: lars.bjorck@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH